Skip to content

Functional capacity and mental health

Functional capacity and mental health: effect of combined strength and aerobic training for middle-aged and elderly adults undergoing treatment for substance use disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10prm4vn
Enrollment
Unknown
Registered
2024-09-10
Start date
2022-05-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Interventions

This is a randomized, two-arm clinical trial with an intervention group and a control group for alcohol users aged 50 and older undergoing treatment at the Addiction Clinic of the Hospital de Clínicas
negotiate treatment goals and the treatment contract
provide a justification for extra-session tasks
provide a rational basis for the treatment
Week 2. Dealing with Cravings: Understand the patient’s experience of cravings
understand the nature of cravi
G11.427.410.698.277

Sponsors

Hospital de Clínicas de Porto Alegre
Lead Sponsor
Hospital de Clínicas de Porto Alegre
Collaborator

Eligibility

Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: To join the sample, participants must meet the following inclusion criteria: Men and women; Age equal to or over 50 years old; Be monitored for the use of alcohol and/or other drugs at the HCPA Addiction Outpatient Clinic; Be clinically fit to perform physical exercise and therefore present a medical certificate stating fitness to practice; Not engaged in a physical exercise program (with more than 2 weekly sessions of light to moderate physical activity for a minimum of 30 minutes); Be able to communicate; Be able to provide consent to participate in the research. The research team has a clinical cardiologist who evaluate and issue a certificate for participants to participate in the research

Exclusion criteria

Exclusion criteria: Participants who meet the following criteria will be excluded: Individuals who present psychotic symptoms and/or cognitive deficits that make it difficult to apply mental health and functional capacity tests; Individuals who have acute or chronic injuries and clinical health problems that prevent the practice of physical exercise

Design outcomes

Primary

MeasureTime frame
Evaluate the scores of functional tests: 6-Minute Walk Test (6MWT), Time Up and Go (TUG) Test, and Dual Task TUG Test. Assess the scores of the Handgrip Strength Test, WHOQOL-BREF Quality of Life Questionnaire, Mini-Mental State Examination (MMSE), and Barkley Deficits in Executive Functioning Scale (BDEFS). It is expected to find improvements in scores following combined training intervention. This will be verified using data analysis methods through means and standard deviations. The homogeneity and normality of the data will be assessed with Levene's and Shapiro-Wilk tests. For normally distributed data, linear mixed models with group effect, time, and group x time interaction will be used. For non-normally distributed data, generalized estimating equations will be applied. Outcomes will be evaluated according to the intention-to-treat principle. For inferential analysis, the significance level will be 5%. Data will be analyzed using the Statistical Package for the Social Sciences (SPSS), version 23.0

Secondary

MeasureTime frame
Evaluate the scores for the assessment of trait-state anxiety and depressive symptoms using the State-Trait Anxiety Inventory (STAI), which consists of 2 self-report scales assessing anxiety as a state (STAI-S) or trait (STAI-T), and the Beck Depression Inventory II (BDI-II), respectively. It is expected to find improvements in scores following combined training intervention. This will be verified using data analysis methods through means and standard deviations. The homogeneity and normality of the data will be assessed with Levene's and Shapiro-Wilk tests. For normally distributed data, linear mixed models with group effect, time, and group x time interaction will be used. For non-normally distributed data, generalized estimating equations will be applied. Outcomes will be evaluated according to the intention-to-treat principle. For inferential analysis, the significance level will be 5%. Data will be analyzed using the Statistical Package for the Social Sciences (SPSS), version 23.0

Countries

Brazil

Contacts

Public ContactCássio Pires

Hospital de Clínicas de Porto Alegre

clpires@hcpa.edu.br55 (51) 33598144

Outcome results

None listed

Source: REBEC (via WHO ICTRP)